# A Trial of Vigil for Participants With Ovarian Cancer

> **NCT02346747** · PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **Gradalis, Inc.** · enrollment: 92 (actual)

## Conditions studied

- Ovarian Cancer
- Ovarian Neoplasms

## Interventions

- **BIOLOGICAL:** Vigil
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT02346747
- **Lead sponsor:** Gradalis, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2015-02
- **Primary completion:** 2028-12
- **Final completion:** 2028-12
- **Target enrollment:** 92 (ACTUAL)
- **Last updated:** 2025-10-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02346747

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02346747, "A Trial of Vigil for Participants With Ovarian Cancer". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT02346747. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*